PDB Short entry for 2DQU HEADER IMMUNE SYSTEM 30-MAY-06 2DQU TITLE CRYSTAL FORM II: HIGH RESOLUTION CRYSTAL STRUCTURE OF THE TITLE 2 COMPLEX OF THE HYDROLYTIC ANTIBODY FAB 6D9 AND A TITLE 3 TRANSITION-STATE ANALOG COMPND MOL_ID: 1; COMPND 2 MOLECULE: IMMUNOGLOBULIN 6D9; COMPND 3 CHAIN: L; COMPND 4 FRAGMENT: FAB FRAGMENT; COMPND 5 SYNONYM: CATALYTIC ANTIBODY 6D9; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: IMMUNOGLOBULIN 6D9; COMPND 8 CHAIN: H; COMPND 9 FRAGMENT: FAB FRAGMENT; COMPND 10 SYNONYM: CATALYTIC ANTIBODY 6D9 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 CELL_LINE: 6D9 MURINE-MURINE HYBRIDOMA; SOURCE 6 SECRETION: ASCITES FLUID; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 9 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 10 ORGANISM_TAXID: 10090; SOURCE 11 CELL_LINE: 6D9 MURINE-MURINE HYBRIDOMA; SOURCE 12 SECRETION: ASCITES FLUID KEYWDS CATALYTIC ANTIBODY, ESTER HYDROLYSIS, ESTEROLYTIC, FAB, KEYWDS 2 IMMUNOGLOBULIN, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR O.KRISTENSEN,D.G.VASSYLYEV,F.TANAKA,N.ITO,K.MORIKAWA,I.FUJII REVDAT 3 24-FEB-09 2DQU 1 VERSN REVDAT 2 29-MAY-07 2DQU 1 JRNL REMARK REVDAT 1 20-JUN-06 2DQU 0 SPRSDE 20-JUN-06 2DQU 1HYY JRNL AUTH M.ODA,N.ITO,T.TSUMURAYA,K.SUZUKI,M.SAKAKURA,I.FUJII JRNL TITL THERMODYNAMIC AND STRUCTURAL BASIS FOR JRNL TITL 2 TRANSITION-STATE STABILIZATION IN JRNL TITL 3 ANTIBODY-CATALYZED HYDROLYSIS JRNL REF J.MOL.BIOL. V. 369 198 2007 JRNL REFN ISSN 0022-2836 JRNL PMID 17428500 JRNL DOI 10.1016/J.JMB.2007.03.023 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH H.MIYASHITA,T.HARA,R.TANIMURA,S.FUKUYAMA,C.CAGNON, REMARK 1 AUTH 2 A.KOHARA,I.FUJII REMARK 1 TITL SITE-DIRECTED MUTAGENESIS OF ACTIVE SITE CONTACT REMARK 1 TITL 2 RESIDUES IN A HYDROLYTIC ABZYME: EVIDENCE FOR AN REMARK 1 TITL 3 ESSENTIAL HISTIDINE INVOLVED IN TRANSITION STATE REMARK 1 TITL 4 STABILIZATION REMARK 1 REF J.MOL.BIOL. V. 267 1247 1997 REMARK 1 REFN ISSN 0022-2836 REMARK 1 PMID 9150409 REMARK 1 DOI 10.1006/JMBI.1997.0938 REMARK 1 REFERENCE 2 REMARK 1 AUTH I.FUJII,F.TANAKA,H.MIYASHITA,R.TANIMURA,K.KINOSHITA REMARK 1 TITL CORRELATION BETWEEN ANTIGEN-COMBINING-SITE REMARK 1 TITL 2 STRUCTURES AND FUNCTIONS WITHIN A PANEL OF REMARK 1 TITL 3 CATALYTIC ANTIBODIES GENERATED AGAINST A SINGLE REMARK 1 TITL 4 TRANSITION STATE ANALOG REMARK 1 REF J.AM.CHEM.SOC. V. 117 6199 1995 REMARK 1 REFN ISSN 0002-7863 REMARK 1 DOI 10.1021/JA00128A006 REMARK 1 REFERENCE 3 REMARK 1 AUTH O.KRISTENSEN,H.MIYASHITA,D.G.VASSYLYEV,F.TANAKA, REMARK 1 AUTH 2 I.FUJII,K.MORIKAWA REMARK 1 TITL CRYSTALLIZATION AND PRELIMINARY X-RAY ANALYSIS: REMARK 1 TITL 2 TRANSITION STATE COMPLEX OF A CHLORAMPHENICOL REMARK 1 TITL 3 PRODRUG ACTIVATION SPECIFIC CATALYTIC ANTIBODY REMARK 1 REF PROTEIN PEPT.LETT. V. 1 252 1995 REMARK 1 REFN ISSN 0929-8665 REMARK 1 REFERENCE 4 REMARK 1 AUTH H.MIYASHITA,T.HARA,R.TANIMURA,F.TANAKA,M.KIKUCHI, REMARK 1 AUTH 2 I.FUJII REMARK 1 TITL A COMMON ANCESTRY FOR MULTIPLE CATALYTIC REMARK 1 TITL 2 ANTIBODIES GENERATED AGAINST A SINGLE REMARK 1 TITL 3 TRANSITION-STATE ANALOG REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 91 6045 1994 REMARK 1 REFN ISSN 0027-8424 REMARK 1 PMID 7938025 REMARK 1 DOI 10.1073/PNAS.91.22.10757A REMARK 1 REFERENCE 5 REMARK 1 AUTH H.MIYASHITA,T.HARA,R.TAMIMURA,F.TANAKA,M.KIKUCHI, REMARK 1 AUTH 2 I.FUJII REMARK 1 TITL A COMMON ANCESTRY FOR MULTIPLE CATALYTIC REMARK 1 TITL 2 ANTIBODIES GENERATED AGAINST A SINGLE REMARK 1 TITL 3 TRANSITION-STATE ANALOG REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 91 10757 1994 REMARK 1 REFN ISSN 0027-8424 REMARK 1 PMID 8016113 REMARK 1 DOI 10.1073/PNAS.91.13.6045 REMARK 1 REFERENCE 6 REMARK 1 AUTH H.MIYASHITA,Y.KARAKI,M.KIKUCHI,I.FUJII REMARK 1 TITL PRODRUG ACTIVATION VIA CATALYTIC ANTIBODIES REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 90 5337 1993 REMARK 1 REFN ISSN 0027-8424 REMARK 1 PMID 8506382 REMARK 1 DOI 10.1073/PNAS.90.11.5337 REMARK 1 REFERENCE 7 REMARK 1 AUTH M.ODA,N.ITO,T.TSUMURAYA,K.SUZUKI,I.FUJII REMARK 1 TITL THERMODYNAMIC AND STRUCTURAL ANALYSES OF REMARK 1 TITL 2 HYDROLYTIC MECHANISM BY CATALYTIC ANTIBODIES REMARK 1 REF TO BE PUBLISHED REMARK 1 REFN REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 14979897.840 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 84.4 REMARK 3 NUMBER OF REFLECTIONS : 38028 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.207 REMARK 3 FREE R VALUE : 0.246 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1898 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.81 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 56.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4028 REMARK 3 BIN R VALUE (WORKING SET) : 0.3360 REMARK 3 BIN FREE R VALUE : 0.3570 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 216 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.024 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3374 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 48 REMARK 3 SOLVENT ATOMS : 257 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 15.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.01000 REMARK 3 B22 (A**2) : 4.50000 REMARK 3 B33 (A**2) : -0.49000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -2.35000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM SIGMAA (A) : 0.27 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.24 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.37 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.50 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 27.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.93 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : OVERALL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.32 REMARK 3 BSOL : 48.36 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : CPD.PAR REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER_REP.TOP REMARK 3 TOPOLOGY FILE 3 : CPD.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2DQU COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 02-JUN-06. REMARK 100 THE RCSB ID CODE IS RCSB025735. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-OCT-94 REMARK 200 TEMPERATURE (KELVIN) : 293 REMARK 200 PH : 8.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-6A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : FUJI REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38032 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 89.0 REMARK 200 DATA REDUNDANCY : 7.300 REMARK 200 R MERGE (I) : 0.08200 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: PDB ENTRY 2DQT REMARK 200 REMARK 200 REMARK: DATA WAS COLLECTED USING THE WEISSENBERG METHOD. REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.05 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: THE PRE-FORMED COMPLEX WAS REMARK 280 CRYSTALLIZED FROM 17% PEG 4000, 50MM TRIS, 0.1MM EDTA, PH 8.3 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 31.52000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4860 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19670 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -33.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN H 131 REMARK 465 THR H 132 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL L 51 -49.56 71.26 REMARK 500 ASP H 173 -9.15 71.46 REMARK 500 ARG H 213 149.71 -170.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CPD H 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2DQT RELATED DB: PDB REMARK 900 THE SAME PROTEIN DBREF 2DQU L 1 214 PDB 2DQU 2DQU 1 214 DBREF 2DQU H 1 215 PDB 2DQU 2DQU 1 215 SEQRES 1 L 219 ASP VAL LEU MET THR GLN THR PRO LEU SER LEU PRO VAL SEQRES 2 L 219 SER LEU GLY ASP GLN ALA SER ILE SER CYS ARG SER SER SEQRES 3 L 219 GLN THR ILE VAL HIS SER ASN GLY ASP THR TYR LEU ASP SEQRES 4 L 219 TRP PHE LEU GLN LYS PRO GLY GLN SER PRO LYS LEU LEU SEQRES 5 L 219 ILE TYR LYS VAL SER ASN ARG PHE SER GLY VAL PRO ASP SEQRES 6 L 219 ARG PHE SER GLY SER GLY SER GLY THR ASP PHE THR LEU SEQRES 7 L 219 LYS ILE SER ARG VAL GLU ALA GLU ASP LEU GLY VAL TYR SEQRES 8 L 219 TYR CYS PHE GLN GLY SER HIS VAL PRO PRO THR PHE GLY SEQRES 9 L 219 GLY GLY THR LYS LEU GLU ILE LYS ARG ALA ASP ALA ALA SEQRES 10 L 219 PRO THR VAL SER ILE PHE PRO PRO SER SER GLU GLN LEU SEQRES 11 L 219 THR SER GLY GLY ALA SER VAL VAL CYS PHE LEU ASN ASN SEQRES 12 L 219 PHE TYR PRO LYS ASP ILE ASN VAL LYS TRP LYS ILE ASP SEQRES 13 L 219 GLY SER GLU ARG GLN ASN GLY VAL LEU ASN SER TRP THR SEQRES 14 L 219 ASP GLN ASP SER LYS ASP SER THR TYR SER MET SER SER SEQRES 15 L 219 THR LEU THR LEU THR LYS ASP GLU TYR GLU ARG HIS ASN SEQRES 16 L 219 SER TYR THR CYS GLU ALA THR HIS LYS THR SER THR SER SEQRES 17 L 219 PRO ILE VAL LYS SER PHE ASN ARG ASN GLU CYS SEQRES 1 H 224 GLU VAL LYS LEU VAL GLU SER GLY GLY GLY LEU VAL LYS SEQRES 2 H 224 PRO GLY GLY SER LEU LYS LEU SER CYS ALA ALA SER GLY SEQRES 3 H 224 PHE THR PHE SER ASN TYR ALA MET SER TRP VAL ARG GLN SEQRES 4 H 224 THR PRO GLU LYS ARG LEU GLU TRP VAL VAL SER ILE SER SEQRES 5 H 224 SER GLY GLY SER ILE TYR TYR LEU ASP SER VAL LYS GLY SEQRES 6 H 224 ARG PHE THR VAL SER ARG ASP ASN ALA ARG ASN ILE LEU SEQRES 7 H 224 TYR LEU GLN MET THR SER LEU ARG SER GLU ASP THR ALA SEQRES 8 H 224 MET TYR PHE CYS ALA ARG VAL SER HIS TYR ASP GLY SER SEQRES 9 H 224 ARG ASP TRP TYR PHE ASP VAL TRP GLY ALA GLY THR SER SEQRES 10 H 224 VAL THR VAL SER SER ALA LYS THR THR PRO PRO SER VAL SEQRES 11 H 224 TYR PRO LEU ALA PRO GLY SER ALA ALA GLN THR ASN SER SEQRES 12 H 224 MET VAL THR LEU GLY CYS LEU VAL LYS GLY TYR PHE PRO SEQRES 13 H 224 GLU PRO VAL THR VAL THR TRP ASN SER GLY SER LEU SER SEQRES 14 H 224 SER GLY VAL HIS THR PHE PRO ALA VAL LEU GLN SER ASP SEQRES 15 H 224 LEU TYR THR LEU SER SER SER VAL THR VAL PRO SER SER SEQRES 16 H 224 THR TRP PRO SER GLU THR VAL THR CYS ASN VAL ALA HIS SEQRES 17 H 224 PRO ALA SER SER THR LYS VAL ASP LYS LYS ILE VAL PRO SEQRES 18 H 224 ARG ASP CYS HET CPD H 501 48 HETNAM CPD [1-(3-DIMETHYLAMINO-PROPYL)-3-ETHYL-UREIDO]-[4-(2,2,2- HETNAM 2 CPD TRIFLUORO-ACETYLAMINO)-BENZYL]PHOSPHINIC ACID-2-(2,2- HETNAM 3 CPD DIHYDRO-ACETYLAMINO)-3-HYDROXY-1-(4-NITROPHENYL)- HETNAM 4 CPD PROPYL ESTER FORMUL 3 CPD C28 H36 CL2 F3 N6 O8 P FORMUL 4 HOH *257(H2 O) HELIX 1 1 GLU L 79 LEU L 83 5 5 HELIX 2 2 SER L 121 SER L 127 1 7 HELIX 3 3 LYS L 183 GLU L 187 1 5 HELIX 4 4 ASN L 212 CYS L 214 5 3 HELIX 5 5 THR H 28 TYR H 32 5 5 HELIX 6 6 ASP H 61 LYS H 64 5 4 HELIX 7 7 ARG H 83 THR H 87 5 5 HELIX 8 8 SER H 156 SER H 158 5 3 HELIX 9 9 PRO H 200 SER H 203 5 4 SHEET 1 A 4 MET L 4 THR L 7 0 SHEET 2 A 4 ALA L 19 SER L 25 -1 O ARG L 24 N THR L 5 SHEET 3 A 4 ASP L 70 ILE L 75 -1 O ILE L 75 N ALA L 19 SHEET 4 A 4 PHE L 62 SER L 67 -1 N SER L 63 O LYS L 74 SHEET 1 B 6 SER L 10 VAL L 13 0 SHEET 2 B 6 THR L 102 ILE L 106 1 O LYS L 103 N LEU L 11 SHEET 3 B 6 GLY L 84 GLN L 90 -1 N TYR L 86 O THR L 102 SHEET 4 B 6 LEU L 33 GLN L 38 -1 N PHE L 36 O TYR L 87 SHEET 5 B 6 LYS L 45 TYR L 49 -1 O ILE L 48 N TRP L 35 SHEET 6 B 6 ASN L 53 ARG L 54 -1 O ASN L 53 N TYR L 49 SHEET 1 C 4 SER L 10 VAL L 13 0 SHEET 2 C 4 THR L 102 ILE L 106 1 O LYS L 103 N LEU L 11 SHEET 3 C 4 GLY L 84 GLN L 90 -1 N TYR L 86 O THR L 102 SHEET 4 C 4 THR L 97 PHE L 98 -1 O THR L 97 N GLN L 90 SHEET 1 D 4 THR L 114 PHE L 118 0 SHEET 2 D 4 GLY L 129 PHE L 139 -1 O VAL L 133 N PHE L 118 SHEET 3 D 4 TYR L 173 THR L 182 -1 O MET L 175 N LEU L 136 SHEET 4 D 4 VAL L 159 TRP L 163 -1 N SER L 162 O SER L 176 SHEET 1 E 4 SER L 153 ARG L 155 0 SHEET 2 E 4 ASN L 145 ILE L 150 -1 N ILE L 150 O SER L 153 SHEET 3 E 4 SER L 191 THR L 197 -1 O GLU L 195 N LYS L 147 SHEET 4 E 4 ILE L 205 ASN L 210 -1 O ILE L 205 N ALA L 196 SHEET 1 F 4 LYS H 3 SER H 7 0 SHEET 2 F 4 LEU H 18 SER H 25 -1 O ALA H 23 N VAL H 5 SHEET 3 F 4 ILE H 77 MET H 82 -1 O MET H 82 N LEU H 18 SHEET 4 F 4 PHE H 67 ASP H 72 -1 N SER H 70 O TYR H 79 SHEET 1 G 6 GLY H 10 VAL H 12 0 SHEET 2 G 6 THR H 107 VAL H 111 1 O THR H 110 N GLY H 10 SHEET 3 G 6 ALA H 88 VAL H 95 -1 N TYR H 90 O THR H 107 SHEET 4 G 6 ALA H 33 GLN H 39 -1 N VAL H 37 O PHE H 91 SHEET 5 G 6 LEU H 45 ILE H 51 -1 O GLU H 46 N ARG H 38 SHEET 6 G 6 ILE H 57 TYR H 59 -1 O TYR H 58 N SER H 50 SHEET 1 H 4 GLY H 10 VAL H 12 0 SHEET 2 H 4 THR H 107 VAL H 111 1 O THR H 110 N GLY H 10 SHEET 3 H 4 ALA H 88 VAL H 95 -1 N TYR H 90 O THR H 107 SHEET 4 H 4 PHE H 100K TRP H 103 -1 O VAL H 102 N ARG H 94 SHEET 1 I 4 SER H 120 LEU H 124 0 SHEET 2 I 4 MET H 135 TYR H 145 -1 O GLY H 139 N LEU H 124 SHEET 3 I 4 LEU H 174 PRO H 184 -1 O VAL H 183 N VAL H 136 SHEET 4 I 4 VAL H 163 THR H 165 -1 N HIS H 164 O SER H 180 SHEET 1 J 4 SER H 120 LEU H 124 0 SHEET 2 J 4 MET H 135 TYR H 145 -1 O GLY H 139 N LEU H 124 SHEET 3 J 4 LEU H 174 PRO H 184 -1 O VAL H 183 N VAL H 136 SHEET 4 J 4 VAL H 169 GLN H 171 -1 N GLN H 171 O LEU H 174 SHEET 1 K 3 THR H 151 TRP H 154 0 SHEET 2 K 3 THR H 194 HIS H 199 -1 O ASN H 196 N THR H 153 SHEET 3 K 3 THR H 204 LYS H 209 -1 O VAL H 206 N VAL H 197 SSBOND 1 CYS L 23 CYS L 88 1555 1555 2.03 SSBOND 2 CYS L 134 CYS L 194 1555 1555 2.04 SSBOND 3 CYS L 214 CYS H 215 1555 1555 2.03 SSBOND 4 CYS H 22 CYS H 92 1555 1555 2.03 SSBOND 5 CYS H 140 CYS H 195 1555 1555 2.03 CISPEP 1 THR L 7 PRO L 8 0 -0.30 CISPEP 2 VAL L 94 PRO L 95 0 0.05 CISPEP 3 TYR L 140 PRO L 141 0 0.36 CISPEP 4 PHE H 146 PRO H 147 0 -0.40 CISPEP 5 GLU H 148 PRO H 149 0 0.08 CISPEP 6 TRP H 188 PRO H 189 0 0.42 SITE 1 AC1 21 ALA H 33 SER H 50 SER H 52 TYR H 58 SITE 2 AC1 21 VAL H 95 HIS H 97 ASP H 99 GLY H 100 SITE 3 AC1 21 TRP H 100I PHE H 100K ALA H 129 ARG H 213 SITE 4 AC1 21 ASP H 214 HOH H 522 HIS L 27D PHE L 89 SITE 5 AC1 21 GLY L 91 SER L 92 VAL L 94 GLU L 213 SITE 6 AC1 21 CYS L 214 CRYST1 58.700 63.040 56.560 90.00 98.75 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017036 0.000000 0.002622 0.00000 SCALE2 0.000000 0.015863 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017889 0.00000